Ultimovacs ASA (ULTI)

Market Closed

13 Jan, 11:35

XOSL

2. 14

-0.03

-1.38%

287.63M Market Cap

- P/E Ratio

0% Div Yield

48,119 Volume

-6 Eps

kr 2.17

Previous Close

Day Range

2.08 2.2

Year Range

1.57 165

Earnings results expected in 5 days

Summary

ULTI closed Monday lower at kr2.14, a decrease of 1.38% from Friday's close, completing a monthly decrease of -9.32% or kr0.22. Over the past 12 months, ULTI stock lost -9.32%.

ULTI is not paying dividends to its shareholders.

The last earnings report, released on Feb 13, 2025, missed the consensus estimates by -3.13%. On average, the company has fell short of earnings expectations by -1.73%, based on the last three reports. The next scheduled earnings report is due on May 05, 2025.

The stock of the company had never split.

The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

Want to track ULTI and more in your Portfolio? 🎯

Get Started For Free

Overview
Earnings

ULTI Chart

No Data

Ultimovacs ASA Dividends

ULTI is not paying dividends to its shareholders.

Ultimovacs ASA Earnings

5 May 2025 (5 Days) Date	- Cons. EPS	- EPS
13 Feb 2025 Date	- Cons. EPS	- EPS
6 Nov 2024 Date	- Cons. EPS	- EPS
21 Aug 2024 Date	- Cons. EPS	- EPS
7 May 2024 Date	- Cons. EPS	- EPS

ULTI earnings

Dividends
Earnings

ULTI is not paying dividends to its shareholders.

5 May 2025 (5 Days) Date	- Cons. EPS	- EPS
13 Feb 2025 Date	- Cons. EPS	- EPS
6 Nov 2024 Date	- Cons. EPS	- EPS
21 Aug 2024 Date	- Cons. EPS	- EPS
7 May 2024 Date	- Cons. EPS	- EPS

ULTI earnings

Ultimovacs ASA (ULTI) FAQ

What is the stock price today?

The current price is kr2.14.

On which exchange is it traded?

Ultimovacs ASA is listed on XFRA.

What is its stock symbol?

The ticker symbol is ULTI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 287.63M.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on May 05, 2025.

Has Ultimovacs ASA ever had a stock split?

Ultimovacs ASA had 0 splits and the recent split was on Apr 01, 2025.

Ultimovacs ASA Profile

Biotechnology Industry	Healthcare Sector	Dr. Carlos de Sousa CEO	XOSL Exchange	NO0010851603 ISIN
NO Country	24 Employees	- Last Dividend	- Last Split	- IPO Date

Overview

Ultimovacs ASA is a pioneering biotech firm grounded in Oslo, Norway, with a mission to innovate in the realm of immunotherapies targeting various cancers. Since its incorporation in 2011, Ultimovacs has been at the forefront of developing novel treatments, focusing on harnessing the body's immune system to fight cancer. Their work revolves around creating vaccines that can train the immune system to recognize and eliminate cancer cells, aiming to provide a universal solution in the battle against this complex disease.

Products and Services

UV1 - Peptide-based Cancer Vaccine

Ultimovacs' flagship product, UV1, stands as a testament to their innovative approach towards cancer treatment. This peptide-based cancer vaccine is designed to elicit a strong and specific T cell response against telomerase, a universal cancer antigen found in over 85% of all cancers. By targeting telomerase, UV1 has the potential to be used across a wide array of cancer types, making it a versatile and groundbreaking approach in the field of oncology. The development of UV1 underpins Ultimovacs' commitment to improving patient outcomes and offering new hope in the fight against cancer.

Contact Information

Address: Ullernchausséen 64, Oslo, Norway, 0379

Phone: 47 41 38 00 80

Website: https://ultimovacs.com

Affiliate Program About Report a Bug Terms Privacy Help Contact Us